Discover the forefront of gene therapy at the 4th Gene Therapy for Muscular Disorders Summit (April 16-18, Boston). Following the groundbreaking approval of Sarepta’s DMD gene therapy in June 2023, our April 2024 gathering explores key challenges in translating research into clinical breakthroughs. With a sharp focus on safety and efficacy, we unite experts to advance transformative treatments for muscular disorders lacking viable options. Join us to propel innovation forward and make a tangible impact on patient care. This is your opportunity to shape the future of muscular disorder treatments in just one event.

Want to learn more? Check out the event guide here: https://ter.li/cjxppp